Literature DB >> 7520210

The effect of chlorthalidone on ventricular ectopic activity in patients with isolated systolic hypertension. The SHEP Study Group.

J B Kostis1, C R Lacy, W D Hall, A C Wilson, N O Borhani, S D Krieger, N M Cosgrove.   

Abstract

In an ancillary study of the Systolic Hypertension in the Elderly Program (SHEP), the effects of diuretics on ventricular ectopic activity were investigated in 186 patients with isolated systolic hypertension. Ventricular premature complexes (VPCs) were examined as the number of VPCs/24 hours, presence of > or = 1 VPC, presence of > or = 10 VPCs/24 hours, and presence of VPC pairs or ventricular tachycardia. Significant changes in VPCs were not observed either in the 92 patients randomized to chlorthalidone stepped-care (12.5 and 25 mg/day) or in the 94 placebo-treated patients (p > 0.1 for all VPC definitions and both groups). Serum potassium decreased from 4.4 +/- 0.5 to 4.1 +/- 0.5 mEq/liter (p = 0.002) in the chlorthalidone group and did not change (4.4 +/- 0.5 to 4.5 +/- 0.4 mEq/liter) in the placebo group. Potassium was prescribed routinely for confirmed hypokalemia < 3.5 mEq/liter. A relation between serum potassium and VPC or change in serum potassium and change in VPC was not observed in the chlorthalidone group. In summary, in patients with isolated systolic hypertension, chlorthalidone in doses that are effective in decreasing stroke and cardiovascular event rates (12.5 or 25 mg/day), did not increase VPCs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520210     DOI: 10.1016/0002-9149(94)90904-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  The impact of serum potassium-influencing antihypertensive drugs on the risk of out-of-hospital cardiac arrest: A case-control study.

Authors:  Fawaz F Alharbi; Patrick C Souverein; Mark C H de Groot; Marieke T Blom; Anthonius de Boer; Olaf H Klungel; Hanno L Tan
Journal:  Br J Clin Pharmacol       Date:  2017-08-16       Impact factor: 4.335

Review 2.  Chlorthalidone: mechanisms of action and effect on cardiovascular events.

Authors:  George C Roush; Venkata Buddharaju; Michael E Ernst; Theodore R Holford
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

3.  Diuretics, hypokalemia, and cardiac arrhythmia: a 20-year controversy.

Authors:  Vasilios Papademetriou
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-02       Impact factor: 3.738

Review 4.  Pharmacotherapy for mild hypertension.

Authors:  Diana Diao; James M Wright; David K Cundiff; Francois Gueyffier
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

5.  Pharmacotherapy for hypertension in adults 60 years or older.

Authors:  Vijaya M Musini; Aaron M Tejani; Ken Bassett; Lorri Puil; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2019-06-05

Review 6.  First-line drugs for hypertension.

Authors:  James M Wright; Vijaya M Musini; Rupam Gill
Journal:  Cochrane Database Syst Rev       Date:  2018-04-18

7.  Severe Hyponatremia Associated with the Use of Angiotensin II Receptor Blocker/thiazide Combinations.

Authors:  Da-Rae Kim; Joo-Hee Cho; Won-Seok Jang; Jin-Sug Kim; Kyung-Hwan Jeong; Tae-Won Lee; Chun-Gyoo Ihm
Journal:  Electrolyte Blood Press       Date:  2013-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.